HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of mupirocin resistance in Staphylococcus pseudintermedius.

Abstract
In the United States, veterinary use of mupirocin is primarily limited to the treatment of canine pyoderma caused by methicillin-resistant Staphylococcus pseudintermedius (MRSP). In this study, only 1 of 581 S. pseudintermedius isolates tested was resistant to mupirocin and carried the high-level mupirocin resistance gene, ileS2, on a plasmid.
AuthorsStacey M Godbeer, Randi M Gold, Sara D Lawhon
JournalJournal of clinical microbiology (J Clin Microbiol) Vol. 52 Issue 4 Pg. 1250-2 (Apr 2014) ISSN: 1098-660X [Electronic] United States
PMID24478408 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • DNA, Bacterial
  • Mupirocin
Topics
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • DNA, Bacterial (chemistry, genetics)
  • Dogs
  • Drug Resistance, Bacterial
  • Genes, Bacterial
  • Molecular Sequence Data
  • Mupirocin (pharmacology)
  • Polymerase Chain Reaction
  • Prevalence
  • Pyoderma (microbiology, veterinary)
  • Sequence Analysis, DNA
  • Staphylococcal Infections (microbiology, veterinary)
  • Staphylococcus (drug effects, genetics, isolation & purification)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: